Moderate to Severe Asthma: News
- Asthma Care: Must-Know Insights for Primary Practice
- ATS 2025 Tezepelumab Curbs Oral Corticosteroid Use in Severe Asthma
- Can Chronic Asthma Be Reversed? Experts Reopen the Debate
- AstraZeneca's 'smoker's Lung' Therapy Meets Main Goals Of Late-stage Asthma Trials
- Treat or Refer? Pulmonologists Share Best Practices
- European Regulators to Review GSK's Asthma Drug Nucala to Treat COPD
- Alert FDA Approves First Biosimilar to Omalizumab
- AAAAI 2025 Race-Based Spirometry Stymies Asthma Diagnosis in Kids
- AAAAI 2025 Stock Inhalers Save ER Trips, Keep Students in School
- Asthma & COPD Patients At Cancer Risk From Microplastics
- Environment Drives Respiratory Health Disparities
- Early-Onset Asthma May Slow Memory Development
- Fasenra Approved in Europe for Rare Blood Vessel Disorder
- ERS 2024 Asthma Remission and EGPA With Biologics
- GSK's Asthma Drug Nucala Meets Main Goal in Study on Treating Smoker's Lungs
- Children With Medicaid Receive Less Specialty Asthma Care
- Asthma Treatment During Pregnancy: Stay the Course!
- Can Chemical Agents and Pollens Induce Food Allergies?
- The Primary Care Show 2024 Asthma: Reduce Reliance on the Blue Inhaler
- ATS 2024 Biologics Improve Outcomes in Patients With COPD, Asthma